Evaluation of quality of life in adult patients with MS switching from injectable therapy i.e. Interferon (Avonex, Betaseron, Extavia, Rebif) or Copaxone® (glatiramer acetate) to oral medication Tecfidera® (BG00012) and their caregivers and evaluating their physical disability, cognitive function and adherence
The purpose of this study is to gather information on how the quality of life for people with relapsing Multiple Sclerosis (MS) who are taking an injectable form of medication for their MS is affected by switching to the oral medication Tecfidera.
Evaluation of quality of life in adult patients with MS switching from injectable therapy i.e. Interferon (Avonex, Betaseron, Extavia, Rebif) or Copaxone® (glatiramer acetate) to oral medication Gilenya® (fingolimod) and their caregivers
The purpose of this study is to gather information on how the quality of life for people with relapsing MS who are taking an injectable form of medication for their MS is affected by switching to the oral medication Gilenya. Volunteers may qualify for this research if they have r...
Screening for Depression in Patients with Multiple Sclerosis
The purpose of this research study is to compare the effectiveness of two screening tools that are used to assess depression. Depression is a common occurrence among patients with multiple sclerosis, and proper screening is very important in the diagnosis and management of depres...
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Ben-Zacharia during 2016 and/or 2017. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Biogen Idec
- EMD Serono, Inc. (Merck & Co., Inc.)
- Genentech, Inc.
- Genzyme Corporation
- Teva Pharmaceutical Industries Ltd.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.